Por: The Atlantic Opinion June 15, 2023
Brand-name drugmakers like to pay lower-cost rivals not to compete—and courts too often let them.Illustration by The Atlantic. Source: Getty.June 15, 2023, 7 AM ETAntiretroviral drugs are one of the pharmaceutical industry’s great achievements. They have turned HIV/AIDS from a death sentence into a treatable condition. Still, even after being on the market for decades, effective antiretrovirals cost a year, making them unaffordable for many... + full article
NBC News USA Business July 16, 2023
When Akorn Pharmaceuticals shut its doors in February, hospitals across the country felt it. The Lake Forest, Illinois-based drugmaker was responsible for producing 75 generic drugs, all of which were pulled from the market when the company closed down. In some cases, the... + más
What Are the Duties of A Trustee? | Forbes
NBA playoffs 2023: Our insiders dissect the Eastern and Western conference finals | ABC7
New York Post USA Tech July 04, 2023
Meta Platforms on Tuesday lost its fight against a German data curb order that strikes at the heart of its business model as Europe’s top court backed the German antitrust watchdog’s power to also investigate privacy breaches. The ruling from the Luxembourg-based Court of... + más
Every NBA finals matchup and winner | ESPN
NHL playoffs 2023 predictions: Post experts’ Stanley Cup picks | New York Post
MarketWatch USA Business May 18, 2023
Teva’s ADR jumped 7.3% on Thursday morning, as investors awaited an investor day presentation scheduled to start at 12 p.m. Eastern. The drugmaker has been struggling since a series of ill-advised acquisitions a decade ago, notably the decision to buy Actavis Generics for... + más
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis | ABC News
The New York Times USA Business February 05, 2023
When Microsoft announced its $70 billion acquisition of the video game maker Activision Blizzard last year, almost everyone involved expected antitrust inquiries from officials in the European Union and Britain, and many thought regulators there would try to block the deal.... + más
Activision insiders fret $69B Microsoft merger could fall apart: sources | New York Post
FTC files suit to stop Microsoft’s $69 billion Activision purchase | Ars Technica
CNBC USA Tech January 27, 2023
In this articleCEO of Alphabet and Google Sundar Pichai in Warsaw, Poland on March 29, 2022.Mateusz Wlodarczyk Nurphoto Getty ImagesThe Department of Justice's to tech empire is an ambitious swing at the company with the potential to rearrange the digital advertising... + más
The DOJ sues Google for ad dominance, wants to break company up | Ars Technica
DOJ antitrust lawyers ask for 10 minutes to speak in Epic's favor at upcoming appeal | 9to5Mac
Forbes USA Tech January 01, 2023
Mark Cuban's Cost Plus Drug Company is making waves. It is seen as a disruptor in generic drug ... [+] pricing. (Photo by Luka Dakskobler/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty Images Mark Cuban's Cost Plus Drug Company (MCCPDC) is... + más
Why Mark Cuban Is Selling Anti-Fungal Ointment for $7.34 | Time
At Least 5 Dead After Boat Collides With Cuban Coast Guard Ship: Cuban Media | NBC 6 South Florida
New York Daily News USA Sports September 24, 2022
Maybe Monday night, and Monday Night Football, the Giants with that kind of stage at home against the Cowboys, the Giants trying to get to 3-0, maybe this will be the night when Daniel Jones looks like a quarterback who can take the Giants back to the Super Bowl someday, and not... + más
Daniel Jones puts up fight, but Cowboys overpower Giants and Sterling Shepard goes down | New York Daily News
Rush appears set to start again as Cowboys host Commanders | Associated Press
About iurex | Privacy Policy | Disclaimer |